3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Polycystic Ovary Syndrome
2
Metabolic Syndrome
1
Malnutrition
1
Liver Failure
1
Insulin Resistance
1
Hyperandrogenism
1
Glucose Intolerance
1
Fibrosis
1
Carcinoma, Hepatocellular
1
Anovulation
1
Interventions
Metformin
12
Clomiphene
6
Inositol
3
maltodextrin
2
artenimol
2
Thioctic Acid
2
Tablets
2
Sugars
2
Spironolactone
2
Pioglitazone
2
Orlistat
2
Contraceptives, Oral
2
Cholecalciferol
2
salicylsalicylic acid
1
licogliflozin
1
follitropin alfa
1
elagolix
1
Vitamin E
1
Vitamin D
1
Tooth Exfoliation
1
Sodium Salicylate
1
Root Planing
1
Resveratrol
1
Quercetin
1
Pentoxifylline
1
Ovulation Induction
1
Linseed Oil
1
Leuprolide
1
Letrozole
1
Inulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Polycystic Ovary Syndrome
×
maltodextrin
×
Clear all
NCT06852365
2026-06-01
COR-PCOS
University of Pennsylvania
Phase 2
Recruiting
100 enrolled
NCT03864068
2026-01-07
INSUPP-PCOS
Milton S. Hershey Medical Center
Phase 2
Completed
154 enrolled